Cited by 20Craniofacial Disorders and TreatmentsGenomics and Rare Diseasesdental development and anomalies

Atypical Crouzon Syndrome with a Novel Cys62Arg Mutation in FGFR2 Presenting with Sagittal Synostosis

Sharma, Vikram P., Wall, Steven A., Lord, Helen, Lester, Tracy, Wilkie, Andrew O.M.·2012·The Cleft Palate Craniofacial Journal

Abstract

The management of a 1-year-old boy with Crouzonoid features is presented with a description of molecular genetic investigations that revealed a previously unreported mutation of the fibroblast growth factor receptor 2 (FGFR2) gene encoding the amino acid substitution p.Cys62Arg within the immunoglobin-like (IgI) domain. The patient presented in atypical fashion with severe sagittal synostosis but only mild exorbitism and hypertelorism. Owing to the progressively increasing size of the cranial occipital bullet, a total calvarial modeling procedure was performed at 8 months of age to correct the craniofacial deformity. Standard genetic testing of the major mutational “hotspots” associated with craniosynostosis was initially negative. However, further testing for atypical sites of mutation revealed a heterozygous nucleotide substitution (c.184T>C) in exon 3 of FGFR2. This mutation has not been previously reported and is only the second to be identified in the IgI domain; it was not present in either parent, indicating that it had arisen de novo. The child remains well 6 months postoperatively but will be monitored more closely compared with the usual protocol for nonsyndromic sagittal synostosis owing to the potential for increased risk of secondary complications. Key learning points from this case include the need for careful phenotypic evaluation of children presenting with apparently isolated sagittal synostosis and genetic testing for atypical mutations if the usual hotspots are negative.

Integrity signals

Registry

Crossref · 10.1597/11-185

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Variants in genes such as FGFR2, TCF12, ERF, KAT6B, ACTB, SH3PXD2B, SALL1, IFT140, SON, CASK, FOXP2, EXTL3, and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevelopmental, or systemic disorders.

    “More broadly, variants in genes such as FGFR2, TCF12, ERF, KAT6B, ACTB, SH3PXD2B, SALL1, IFT140, SON, CASK, FOXP2, EXTL3, and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevelopmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sharma, V. P., Wall, S. A., Lord, H., Lester, T., & Wilkie, A. O. M.
Affiliations
  • John Radcliffe Hospital (GB)
  • Churchill Hospital (GB)
Corresponding author
Wilkie, Andrew O.M.
Venue
The Cleft Palate Craniofacial Journal
Published
2012-05
Volume
49
Issue
3
Pages
373-377
ISSN
  • 1055-6656 (ISSN-L)
  • 1545-1569
OpenAlex
W2148237826
Cited by
20
References
18
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 3 · 2012: 2
FWCI
1.00
Type
journal article
Language
en
Open access
closed
Locations
  • The Cleft Palate-Craniofacial Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute for Health and Care Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Craniofacial Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › dental development and anomalies
Keywords
Crouzon syndrome, FGFR2, sagittal synostosis, craniosynostosis, de novo mutations, craniofacial deformities, exorbitism, hypertelorism
MeSH terms
Craniofacial Dysostosis, Craniosynostoses, Humans, Infant, Male, Mutation, Tomography, X-Ray Computed, Amino Acid Substitution, Receptor, Fibroblast Growth Factor, Type 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review